West Pharmaceutical Services (WST)
EBITDA Growth
13.50%
Quarterly · Period ending:
WST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported13.50%period ending
Latest reported13.50%period ending
WST Quarterly EBITDA YoY % (33.49% → 13.50%)
Year-over-year change
High-resolution chart · PNG
WST ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -59.4203% | |
| -45.0331% | |
| -44.2786% | |
| -37.931% | |
| -69.9346% | |
| -6.2112% | |
| 22.561% | |
| 227.0073% | |
| 168.4211% | |
| 26.7717% | |
| -4.6512% | |
| -193.1973% | |
| 8.2278% | |
| 10.4348% | |
| 24.6377% | |
| 20.4918% | |
| 42.3423% | |
| 41.9753% | |
| 0% | |
| -20.2614% | |
| 0.9091% | |
| -17.3469% | |
| 6.9767% | |
| 14.1791% | |
| -6.7797% | |
| 8.8889% | |
| 16.2162% | |
| 45.6522% | |
| 43.9024% | |
| 13.9241% | |
| -6.7227% | |
| -19.2982% | |
| 132.4111% | |
| 5.3333% | |
| 54.5455% | |
| 28.0899% | |
| -5,160% | |
| 31.5789% | |
| 32.7586% | |
| -6.3158% | |
| 100.2592% | |
| -91.7867% | |
| -92.7044% | |
| -88.1398% | |
| -5.7566% | |
| 0.5797% | |
| 6.7114% | |
| 15.5844% | |
| -16.2524% | |
| 21.0526% | |
| 9.7202% | |
| 11.9548% | |
| -9.1858% | |
| 0% | |
| 5.5988% | |
| 16.3534% | |
| -20.8579% | |
| 33.4895% |